ANXA2 and metabolic dysfunction-associated steatohepatitis: Masson and immunohistochemical staining revealed that, overexpression of Anxa2 aggravated liver fibrosis in NASH mice, and this pro-fibrotic effect was significantly reversed by the inhibition of Caspase-1 (Fig. 8B).